Astrea Bioseparations joins Biotage, enabling groundbreaking chromatography solutions

Kieran Murphy and Kugan Sathiyanandarajah become members of the Biotage board of directors   Uppsala, Sweden – Biotage has completed the acquisition of Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences, a life sciences tools platform created by KKR. Astrea’s over 150 employees worldwide will join Biotage, and the company’s production sites in Cambridge, [...]

PL BioScience and Macopharma enter into a Patent License and Assignment Agreement regarding Human Platelet Lysate (HPL) cell culture supplements.

The companies agree to a worldwide Human Platelet Lysate (HPL) Patent License and Assignment Agreement, including redirection of HPL customers from Macopharma to PL BioScience. AACHEN, Germany -- PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, today announced a Patent License [...]

GT Molecular Announces Entry into the Cancer Molecular Assay Market with two PCR Multiplex Panels for the EGFR and KRAS Genes

Highly multiplexed, patented and patent-pending GT-Plex™ PCR assays for low-level, reliable mutation detection These kits are for Research Use Only (RUO) Not for use in diagnostic purposes FORT COLLINS, Colo. -- GT Molecular, Inc., a company providing ultrasensitive PCR assays for cancer research, pathogen detection, and wastewater-based epidemiology testing is entering the cancer molecular assay [...]

Using AI to Analyze Data Automatically, Support for hundreds of Residual Pesticides Release of Peakintelligence for GCMS Ver. 2, AI Software for GC-MS/MS

Shimadzu Corporation released the Peakintelligence for GCMS Ver. 2 software for triple quadrupole gas chromatograph mass spectrometers (GC-MS/MS) on June 1. This software makes it possible for anyone to easily analyze data acquired from a GC-MS/MS using Shimadzu’s proprietary artificial intelligence (AI) algorithms. In addition to the Smart Metabolites Database *1, which was introduced in Ver.1 *2 released [...]

Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research

RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and CeGaT GmbH, a global provider of sequencing services for research, clinical studies, and [...]

Innovative, fully defined hydrogel sets new benchmark in 3D Cell Culture.

AMSBIO announce MatriMix – a groundbreaking 3D culture substrate. This pioneering hydrogel sets a new benchmark in the field, containing fully defined components, including medical grade collagens, laminin-511 E8 fragments, and hyaluronic acid. The high lot-to-lot consistency of MatriMix enables researchers to obtain highly reproducible results. MatriMix overcomes the limitations of current 3D substrates, enabling cutting-edge applications such as [...]

DNAnexus Platform Streamlines Access and Analysis for Large-Scale Proteomics Data

Company to host webinar featuring tips for managing large-scale proteomics data  on UK Biobank Research Analysis Platform   MOUNTAIN VIEW, Calif. —  DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its core platform and Cohort Browser are now optimized for accessing and analyzing large-scale proteomics [...]

Vazyme Signs Global Strategic Cooperation Agreement with Azenta

NANJING, China -- Vazyme (688105.SH), China's leading biotechnology company, has officially signed a global strategic cooperation agreement with Azenta Life Sciences ("Azenta", Nasdaq: AZTA), which will promote to establish "one-stop" service process for both companies in the fields of next-generation sequencing, automated library preparation, raw material supply, experimental consumables, sample storage and more. Dr. Nie Junwei, General Manager of [...]

Mission Bio Launches Tapestri® v3 to Rapidly Accelerate Rare Cell Detection Applications for Translational Research and Precision Therapeutics

New Tapestri® v3 brings a higher number of cells captured and greater standardization and robustness to single-cell DNA and multi-omics workflows to empower customer success SOUTH SAN FRANCISCO, CA – Mission Bio, Inc. the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced breakthrough improvements to the Tapestri® Platform and its core chemistry that enable highly [...]

Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research

RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and CeGaT GmbH, a global provider of sequencing services for research, clinical studies, and [...]

Access IBO on Knowledge Center